Page last updated: 2024-11-05

tritriacontane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tritriacontane is a saturated hydrocarbon with the formula C32H66. It is a white, waxy solid that is found in a variety of natural sources, including beeswax, petroleum, and plants. Tritriacontane is used in a number of applications, including as a lubricant, a plasticizer, and a component of candles. The compound is also being investigated for its potential use in the production of biofuels. Tritriacontane is a relatively inert compound, and it is not known to have any significant biological effects. It is, however, a component of some plant waxes, which are known to have antifungal and antibacterial properties.'

tritriacontane : A long-chain alkane consisting of an unbranched chain of 33 carbon atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12411
CHEBI ID9751
MeSH IDM0192659

Synonyms (22)

Synonym
CHEBI:9751
ch3-[ch2]31-ch3
n-tritriacontane
C08393
630-05-7
tritriacontane
tritriacontane, 98%
BBB0CE2D-089E-4B4E-9705-7FA899DCAF8B
T0968
LMFA11000590
unii-4y81q52008
hsdb 8363
4y81q52008 ,
SUJUOAZFECLBOA-UHFFFAOYSA-N
DTXSID5075444
mfcd00010187
tritriacontane, purum, >=97.0% (gc)
tritriacontane, analytical standard
tritriacontane; n-tritriacontane
Q151134
T72740
BS-49205
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
long-chain alkaneAny alkane having a chain length of at least 13 carbon atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.35 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]